nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—SLC18A2—Parkinson's disease	0.8	1	CbGaD
Ephedrine—SLC18A2—adrenal medulla—Parkinson's disease	0.0148	0.208	CbGeAlD
Ephedrine—SLC6A2—locus ceruleus—Parkinson's disease	0.00761	0.107	CbGeAlD
Ephedrine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00601	0.0844	CbGeAlD
Ephedrine—SLC18A2—telencephalic ventricle—Parkinson's disease	0.00591	0.0829	CbGeAlD
Ephedrine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00404	0.0567	CbGeAlD
Ephedrine—SLC6A2—nerve—Parkinson's disease	0.00227	0.0319	CbGeAlD
Ephedrine—SLC18A2—brainstem—Parkinson's disease	0.0016	0.0224	CbGeAlD
Ephedrine—ADRA1A—hindbrain—Parkinson's disease	0.00158	0.0222	CbGeAlD
Ephedrine—SLC18A2—forebrain—Parkinson's disease	0.00154	0.0217	CbGeAlD
Ephedrine—ACHE—medulla oblongata—Parkinson's disease	0.00114	0.0161	CbGeAlD
Ephedrine—SLC18A2—medulla oblongata—Parkinson's disease	0.00112	0.0156	CbGeAlD
Ephedrine—ACHE—midbrain—Parkinson's disease	0.00105	0.0147	CbGeAlD
Ephedrine—ACHE—spinal cord—Parkinson's disease	0.00102	0.0143	CbGeAlD
Ephedrine—SLC18A2—midbrain—Parkinson's disease	0.00102	0.0143	CbGeAlD
Ephedrine—SLC6A2—brainstem—Parkinson's disease	0.000976	0.0137	CbGeAlD
Ephedrine—SLC6A2—forebrain—Parkinson's disease	0.000942	0.0132	CbGeAlD
Ephedrine—ADRA1A—brainstem—Parkinson's disease	0.000907	0.0127	CbGeAlD
Ephedrine—SLC18A2—head—Parkinson's disease	0.000884	0.0124	CbGeAlD
Ephedrine—ADRA1A—forebrain—Parkinson's disease	0.000876	0.0123	CbGeAlD
Ephedrine—SLC18A2—nervous system—Parkinson's disease	0.000838	0.0118	CbGeAlD
Ephedrine—ACHE—cerebellum—Parkinson's disease	0.000809	0.0114	CbGeAlD
Ephedrine—SLC18A2—central nervous system—Parkinson's disease	0.000807	0.0113	CbGeAlD
Ephedrine—BCHE—brainstem—Parkinson's disease	0.000807	0.0113	CbGeAlD
Ephedrine—SLC18A2—cerebellum—Parkinson's disease	0.000788	0.0111	CbGeAlD
Ephedrine—BCHE—forebrain—Parkinson's disease	0.000778	0.0109	CbGeAlD
Ephedrine—ADRA1A—cardiovascular system—Parkinson's disease	0.00074	0.0104	CbGeAlD
Ephedrine—SLC6A2—medulla oblongata—Parkinson's disease	0.000681	0.00955	CbGeAlD
Ephedrine—BCHE—cardiovascular system—Parkinson's disease	0.000658	0.00924	CbGeAlD
Ephedrine—ACHE—brain—Parkinson's disease	0.000657	0.00922	CbGeAlD
Ephedrine—SLC18A2—brain—Parkinson's disease	0.00064	0.00899	CbGeAlD
Ephedrine—BCHE—medulla oblongata—Parkinson's disease	0.000562	0.00789	CbGeAlD
Ephedrine—Dextroamphetamine—SLC18A2—Parkinson's disease	0.00056	0.0728	CrCbGaD
Ephedrine—SLC6A2—head—Parkinson's disease	0.000539	0.00757	CbGeAlD
Ephedrine—BCHE—midbrain—Parkinson's disease	0.000514	0.00721	CbGeAlD
Ephedrine—SLC6A2—nervous system—Parkinson's disease	0.000511	0.00718	CbGeAlD
Ephedrine—BCHE—spinal cord—Parkinson's disease	0.000502	0.00704	CbGeAlD
Ephedrine—ADRA1A—head—Parkinson's disease	0.000501	0.00704	CbGeAlD
Ephedrine—SLC6A2—central nervous system—Parkinson's disease	0.000492	0.00691	CbGeAlD
Ephedrine—ADRA1A—nervous system—Parkinson's disease	0.000475	0.00667	CbGeAlD
Ephedrine—ADRA1A—central nervous system—Parkinson's disease	0.000458	0.00642	CbGeAlD
Ephedrine—Amphetamine—SLC18A2—Parkinson's disease	0.000451	0.0587	CrCbGaD
Ephedrine—ADRA1A—cerebellum—Parkinson's disease	0.000447	0.00628	CbGeAlD
Ephedrine—BCHE—head—Parkinson's disease	0.000446	0.00625	CbGeAlD
Ephedrine—BCHE—nervous system—Parkinson's disease	0.000423	0.00593	CbGeAlD
Ephedrine—Methamphetamine—SLC18A2—Parkinson's disease	0.000418	0.0544	CrCbGaD
Ephedrine—BCHE—central nervous system—Parkinson's disease	0.000407	0.00571	CbGeAlD
Ephedrine—Phentermine—MAOB—Parkinson's disease	0.000403	0.0524	CrCbGaD
Ephedrine—BCHE—cerebellum—Parkinson's disease	0.000398	0.00558	CbGeAlD
Ephedrine—SLC6A2—brain—Parkinson's disease	0.000391	0.00548	CbGeAlD
Ephedrine—Selegiline—MAOB—Parkinson's disease	0.000373	0.0485	CrCbGaD
Ephedrine—ADRA1A—brain—Parkinson's disease	0.000363	0.0051	CbGeAlD
Ephedrine—BCHE—brain—Parkinson's disease	0.000323	0.00453	CbGeAlD
Ephedrine—Phenylpropanolamine—MAOA—Parkinson's disease	0.000317	0.0412	CrCbGaD
Ephedrine—Amphetamine—MAOB—Parkinson's disease	0.00031	0.0403	CrCbGaD
Ephedrine—Phenylpropanolamine—DRD1—Parkinson's disease	0.000288	0.0375	CrCbGaD
Ephedrine—Methamphetamine—MAOB—Parkinson's disease	0.000287	0.0373	CrCbGaD
Ephedrine—Phentermine—MAOA—Parkinson's disease	0.000282	0.0367	CrCbGaD
Ephedrine—Phenylpropanolamine—SLC6A3—Parkinson's disease	0.000273	0.0355	CrCbGaD
Ephedrine—Pseudoephedrine—MAOA—Parkinson's disease	0.000268	0.0348	CrCbGaD
Ephedrine—Selegiline—MAOA—Parkinson's disease	0.000261	0.034	CrCbGaD
Ephedrine—Phentermine—SLC6A3—Parkinson's disease	0.000243	0.0317	CrCbGaD
Ephedrine—Dextroamphetamine—SLC6A3—Parkinson's disease	0.000232	0.0302	CrCbGaD
Ephedrine—Pseudoephedrine—SLC6A3—Parkinson's disease	0.000231	0.03	CrCbGaD
Ephedrine—Pseudoephedrine—TNF—Parkinson's disease	0.000214	0.0279	CrCbGaD
Ephedrine—Methamphetamine—MAOA—Parkinson's disease	0.000201	0.0262	CrCbGaD
Ephedrine—Amphetamine—SLC6A3—Parkinson's disease	0.000187	0.0243	CrCbGaD
Ephedrine—Methamphetamine—SLC6A3—Parkinson's disease	0.000173	0.0226	CrCbGaD
Ephedrine—Atomoxetine—SLC6A3—Parkinson's disease	0.000171	0.0222	CrCbGaD
Ephedrine—Benzyl alcohol—CYP2E1—Parkinson's disease	0.000168	0.0219	CrCbGaD
Ephedrine—Selegiline—CYP2E1—Parkinson's disease	0.000161	0.021	CrCbGaD
Ephedrine—Amphetamine—DRD2—Parkinson's disease	0.000139	0.0181	CrCbGaD
Ephedrine—Phentermine—CYP2D6—Parkinson's disease	0.000128	0.0166	CrCbGaD
Ephedrine—Benzyl alcohol—CYP2D6—Parkinson's disease	0.000123	0.016	CrCbGaD
Ephedrine—Dextroamphetamine—CYP2D6—Parkinson's disease	0.000122	0.0159	CrCbGaD
Ephedrine—Pseudoephedrine—CYP2D6—Parkinson's disease	0.000121	0.0158	CrCbGaD
Ephedrine—Selegiline—CYP2D6—Parkinson's disease	0.000118	0.0154	CrCbGaD
Ephedrine—Amphetamine—CYP2D6—Parkinson's disease	9.84e-05	0.0128	CrCbGaD
Ephedrine—Atomoxetine—HTR2A—Parkinson's disease	9.81e-05	0.0128	CrCbGaD
Ephedrine—Methamphetamine—CYP2D6—Parkinson's disease	9.11e-05	0.0119	CrCbGaD
Ephedrine—Atomoxetine—CYP2D6—Parkinson's disease	8.97e-05	0.0117	CrCbGaD
Ephedrine—Selegiline—ABCB1—Parkinson's disease	8.45e-05	0.011	CrCbGaD
Ephedrine—ADRA1A—GPCR ligand binding—GRM5—Parkinson's disease	7.66e-05	0.000631	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—DCTN1—Parkinson's disease	7.63e-05	0.000629	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	7.59e-05	0.000625	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	7.59e-05	0.000625	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—EDN1—Parkinson's disease	7.59e-05	0.000625	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ND3—Parkinson's disease	7.49e-05	0.000617	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MCCC1—Parkinson's disease	7.49e-05	0.000617	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NDUFB11—Parkinson's disease	7.48e-05	0.000617	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—RPL14—Parkinson's disease	7.48e-05	0.000616	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—RPL23A—Parkinson's disease	7.48e-05	0.000616	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	7.42e-05	0.000612	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	7.33e-05	0.000604	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	7.33e-05	0.000604	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	7.31e-05	0.000602	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	7.24e-05	0.000597	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GPR37—Parkinson's disease	7.17e-05	0.000591	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—DGKQ—Parkinson's disease	7.17e-05	0.000591	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	7.17e-05	0.000591	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GCH1—Parkinson's disease	7.14e-05	0.000588	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—OMD—Parkinson's disease	7.04e-05	0.00058	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TALDO1—Parkinson's disease	7.04e-05	0.00058	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—RPS8—Parkinson's disease	6.97e-05	0.000575	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	6.94e-05	0.000572	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	6.83e-05	0.000563	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	6.82e-05	0.000562	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	6.79e-05	0.000559	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	6.73e-05	0.000555	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NDUFB11—Parkinson's disease	6.67e-05	0.00055	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—RPL23A—Parkinson's disease	6.67e-05	0.00055	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—RPL14—Parkinson's disease	6.67e-05	0.00055	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—HTR2A—Parkinson's disease	6.64e-05	0.000547	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	6.6e-05	0.000544	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	6.57e-05	0.000542	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PPP1R1B—Parkinson's disease	6.56e-05	0.000541	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	6.54e-05	0.000539	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—ADORA2A—Parkinson's disease	6.51e-05	0.000537	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	6.49e-05	0.000535	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.44e-05	0.000531	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	6.39e-05	0.000527	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GCH1—Parkinson's disease	6.37e-05	0.000525	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—DBH—Parkinson's disease	6.36e-05	0.000524	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—FBP1—Parkinson's disease	6.36e-05	0.000524	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GBA—Parkinson's disease	6.36e-05	0.000524	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	6.28e-05	0.000517	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	6.28e-05	0.000517	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—RPS8—Parkinson's disease	6.22e-05	0.000513	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	6.2e-05	0.000511	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	6.18e-05	0.00051	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	6.16e-05	0.000507	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	6.08e-05	0.000501	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GRK5—Parkinson's disease	5.99e-05	0.000493	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	5.94e-05	0.000489	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	5.9e-05	0.000486	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	5.78e-05	0.000476	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	5.78e-05	0.000476	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.74e-05	0.000473	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	5.7e-05	0.00047	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—DBH—Parkinson's disease	5.68e-05	0.000468	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GBA—Parkinson's disease	5.68e-05	0.000468	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—FBP1—Parkinson's disease	5.68e-05	0.000468	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—HTR1A—Parkinson's disease	5.65e-05	0.000466	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	5.63e-05	0.000464	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	5.59e-05	0.000461	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—TAC1—Parkinson's disease	5.57e-05	0.000459	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.49e-05	0.000453	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—DRD1—Parkinson's disease	5.46e-05	0.00045	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GRK5—Parkinson's disease	5.44e-05	0.000448	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GRM4—Parkinson's disease	5.37e-05	0.000443	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	5.32e-05	0.000438	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—DRD3—Parkinson's disease	5.29e-05	0.000436	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.28e-05	0.000435	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	5.24e-05	0.000432	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	5.23e-05	0.000431	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	5.13e-05	0.000423	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	5.12e-05	0.000422	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	5.12e-05	0.000422	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VPS35—Parkinson's disease	5.12e-05	0.000422	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	5.11e-05	0.000421	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PENK—Parkinson's disease	5.09e-05	0.00042	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	5.03e-05	0.000414	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GRM4—Parkinson's disease	4.88e-05	0.000402	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—HTR7—Parkinson's disease	4.78e-05	0.000394	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—DRD2—Parkinson's disease	4.78e-05	0.000394	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	4.75e-05	0.000392	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	4.69e-05	0.000386	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—DDC—Parkinson's disease	4.67e-05	0.000385	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PDYN—Parkinson's disease	4.66e-05	0.000384	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	4.63e-05	0.000381	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PENK—Parkinson's disease	4.62e-05	0.000381	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.59e-05	0.000378	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	4.45e-05	0.000367	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTA4—Parkinson's disease	4.41e-05	0.000363	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.4e-05	0.000363	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	4.4e-05	0.000362	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.35e-05	0.000359	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GRM5—Parkinson's disease	4.33e-05	0.000357	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DGKQ—Parkinson's disease	4.24e-05	0.000349	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GPR37—Parkinson's disease	4.24e-05	0.000349	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PDYN—Parkinson's disease	4.23e-05	0.000348	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—DDC—Parkinson's disease	4.17e-05	0.000343	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—IGF2—Parkinson's disease	4.16e-05	0.000343	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	4.14e-05	0.000341	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	4.1e-05	0.000338	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	4.05e-05	0.000334	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	4.04e-05	0.000333	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PLA2G6—Parkinson's disease	3.97e-05	0.000327	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTA4—Parkinson's disease	3.93e-05	0.000324	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GRM5—Parkinson's disease	3.93e-05	0.000324	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MAOB—Parkinson's disease	3.93e-05	0.000324	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.88e-05	0.00032	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	3.88e-05	0.00032	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPP1R1B—Parkinson's disease	3.88e-05	0.000319	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	3.86e-05	0.000318	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—EDN1—Parkinson's disease	3.83e-05	0.000315	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	3.8e-05	0.000313	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.74e-05	0.000308	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	3.73e-05	0.000307	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	3.71e-05	0.000306	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	3.68e-05	0.000303	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	3.61e-05	0.000298	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PLA2G6—Parkinson's disease	3.54e-05	0.000292	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	3.51e-05	0.000289	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MAOB—Parkinson's disease	3.51e-05	0.000289	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	3.48e-05	0.000287	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	3.45e-05	0.000285	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RIT2—Parkinson's disease	3.39e-05	0.000279	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	3.39e-05	0.000279	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.37e-05	0.000278	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—HTR2A—Parkinson's disease	3.35e-05	0.000276	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ADORA2A—Parkinson's disease	3.34e-05	0.000275	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.34e-05	0.000275	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PENK—Parkinson's disease	3.3e-05	0.000272	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAG—Parkinson's disease	3.3e-05	0.000272	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	3.28e-05	0.00027	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	3.27e-05	0.000269	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	3.27e-05	0.000269	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GRK5—Parkinson's disease	3.21e-05	0.000265	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—HTR1A—Parkinson's disease	3.19e-05	0.000263	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—TAC1—Parkinson's disease	3.15e-05	0.000259	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	3.08e-05	0.000254	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	3.06e-05	0.000252	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	3.02e-05	0.000249	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	2.99e-05	0.000246	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	2.97e-05	0.000244	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	2.97e-05	0.000244	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP2D6—Parkinson's disease	2.92e-05	0.000241	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	2.9e-05	0.000239	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	2.88e-05	0.000237	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CTGF—Parkinson's disease	2.87e-05	0.000236	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	2.86e-05	0.000235	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	2.84e-05	0.000234	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	2.81e-05	0.000231	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	2.8e-05	0.000231	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.79e-05	0.00023	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—INS—Parkinson's disease	2.76e-05	0.000228	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	2.73e-05	0.000225	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	2.73e-05	0.000225	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	2.71e-05	0.000224	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	2.7e-05	0.000223	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	2.7e-05	0.000223	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP2E1—Parkinson's disease	2.67e-05	0.00022	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NQO1—Parkinson's disease	2.64e-05	0.000218	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	2.62e-05	0.000216	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP2D6—Parkinson's disease	2.61e-05	0.000215	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TH—Parkinson's disease	2.6e-05	0.000215	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CTGF—Parkinson's disease	2.56e-05	0.000211	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.53e-05	0.000209	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYCS—Parkinson's disease	2.5e-05	0.000206	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	2.5e-05	0.000206	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—INS—Parkinson's disease	2.46e-05	0.000203	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	2.46e-05	0.000203	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	2.45e-05	0.000202	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	2.45e-05	0.000202	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	2.39e-05	0.000197	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP2E1—Parkinson's disease	2.38e-05	0.000196	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	2.37e-05	0.000196	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NQO1—Parkinson's disease	2.36e-05	0.000194	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	2.35e-05	0.000194	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TH—Parkinson's disease	2.32e-05	0.000191	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	2.32e-05	0.000191	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.29e-05	0.000189	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYCS—Parkinson's disease	2.23e-05	0.000184	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—COMT—Parkinson's disease	2.21e-05	0.000182	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTP1—Parkinson's disease	2.2e-05	0.000182	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—INSR—Parkinson's disease	2.2e-05	0.000182	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MAOA—Parkinson's disease	2.2e-05	0.000181	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—HMOX1—Parkinson's disease	2.17e-05	0.000179	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	2.16e-05	0.000178	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ABCB1—Parkinson's disease	2.09e-05	0.000172	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGB—Parkinson's disease	2.08e-05	0.000172	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	2.08e-05	0.000171	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	2.07e-05	0.000171	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.06e-05	0.00017	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	2.04e-05	0.000168	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	2.04e-05	0.000168	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTM1—Parkinson's disease	2.02e-05	0.000167	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	2e-05	0.000165	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—COMT—Parkinson's disease	1.97e-05	0.000163	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	1.97e-05	0.000163	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTP1—Parkinson's disease	1.97e-05	0.000162	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	1.96e-05	0.000162	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MAOA—Parkinson's disease	1.96e-05	0.000162	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPX1—Parkinson's disease	1.94e-05	0.00016	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HMOX1—Parkinson's disease	1.94e-05	0.00016	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	1.94e-05	0.00016	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.89e-05	0.000156	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ABCB1—Parkinson's disease	1.86e-05	0.000153	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	1.82e-05	0.00015	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	1.81e-05	0.000149	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—Parkinson's disease	1.81e-05	0.000149	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—Parkinson's disease	1.79e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	1.75e-05	0.000144	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	1.75e-05	0.000144	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPX1—Parkinson's disease	1.73e-05	0.000143	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	1.72e-05	0.000142	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.72e-05	0.000142	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	1.71e-05	0.000141	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	1.69e-05	0.000139	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOE—Parkinson's disease	1.67e-05	0.000137	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	1.65e-05	0.000136	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	1.6e-05	0.000132	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—Parkinson's disease	1.6e-05	0.000132	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.5e-05	0.000123	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOE—Parkinson's disease	1.49e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	1.47e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	1.45e-05	0.000119	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	1.45e-05	0.000119	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—INS—Parkinson's disease	1.42e-05	0.000117	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	1.42e-05	0.000117	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	1.4e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NGF—Parkinson's disease	1.29e-05	0.000106	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—INS—Parkinson's disease	1.27e-05	0.000105	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	1.23e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	1.21e-05	0.0001	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	1.17e-05	9.68e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	1.16e-05	9.56e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOE—Parkinson's disease	1.14e-05	9.4e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	1.07e-05	8.79e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	1.02e-05	8.37e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—INS—Parkinson's disease	9.75e-06	8.03e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	9.44e-06	7.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	8.06e-06	6.64e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	7.26e-06	5.98e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	7.21e-06	5.94e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	6.67e-06	5.5e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	6e-06	4.95e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	5.96e-06	4.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	5.52e-06	4.55e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—Parkinson's disease	4.26e-06	3.51e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	3.52e-06	2.9e-05	CbGpPWpGaD
